Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

41-50 of 4090 results

Catalogue Number:

PX-TA1576

Category:

G

Amivantamab Biosimilar – Anti-EGFR/ ME/ RCCP2 mAb – Research Grade

Target: EGFR/ ME/ RCCP2
Target Alias Name: Amivantamab /JNJ-61186372/JNJ-6372/EGFR/ ME/ RCCP2/anti-EGFR/ ME/ RCCP2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1643

Category:

G

Amlitelimab Biosimilar – Anti-TNFSF4 mAb – Research Grade

Target: TNFSF4
Target Alias Name: Amlitelimab/IMMUNOGLOBULIN G4 (235-PROLINE/242-GLUTAMIC ACID)/ ANTI-(HUMAN OX40 LIGAND) (HUMAN MONOCLONAL KY1005-2D10 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL KY1005-2D10 .KAPPA.-CHAIN/ KY1005/ KY-1005/ KY1005-2D10/ KY-1005-2D10/TNFSF4/anti-TNFSF5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1799

Category:

G

Amubarvimab Biosimilar – Anti-Spike RBD mAb – Research Grade

Target: Spike RBD
Target Alias Name: Amubarvimab/BRII 196/ BRII-196/ BRII196/Spike RBD/anti-Spike RBD
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1204

Category:

G

Anatumomab Biosimilar – Anti-TAG-72 mAb – Research Grade

Target: TAG-72
Target Alias Name: Anatumomab/ABR-214936/pMB125/TAG-72/anti-TAG-72
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Fab-G1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1808

Category:

G

Anbenitamab Biosimilar – Anti-ERBB2 (Domain II)/ERBB2 (Domain IV) mAb – Research Grade

Target: ERBB2 (Domain II)/ERBB2 (Domain IV)
Target Alias Name: Anbenitamab//ERBB2 (Domain II)/ERBB2 (Domain IV)/anti-ERBB2 (Domain II)/ERBB2 (Domain IV)
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa/IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1371

Category:

G

Andecaliximab Biosimilar – Anti-MMP9 mAb – Research Grade

Target: MMP9
Target Alias Name: Andecaliximab/GS-5745/MMP9/anti-MMP9
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1330

Category:

G

Anetumab Biosimilar – Anti-MSLN mAb – Research Grade

Target: MSLN
Target Alias Name: Anetumab/BAY 94-9343/unconjugated:BAY 86-1903/MSLN/anti-MSLN
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1332

Category:

G

Anifrolumab Biosimilar – Anti-IFNAR1 mAb – Research Grade

Target: IFNAR1
Target Alias Name: Anifrolumab/MDX-1333/MEDI-546/IFNAR1/anti-IFNAR1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1809

Category:

G

Anivovetmab Biosimilar – Anti-VP2 (Canine) mAb – Research Grade

Target: VP2 (Canine)
Target Alias Name: Anivovetmab//VP2 (Canine)/anti-VP2 (Canine)
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1165

Category:

G

Anrukinzumab Biosimilar – Anti-IL13 mAb – Research Grade

Target: IL13
Target Alias Name: Anrukinzumab/IMA-638/IL13/anti-IL13
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression